Recent Updates on Voting Rights and Shares for Phaxiam Biotech
In today's fast-paced financial environment, keeping track of voting rights and shares is essential for investors. A recent update from Phaxiam Biotech highlights the total number of shares and voting rights as of the end of the month.
Key Financial Information
Phaxiam Biotech, listed on the Euronext Paris exchange under the symbol PHXM, has given detailed insights into their share capital. This update is vital for stakeholders, helping them to understand the voting power associated with their shares.
Understanding Share Capital
As of the latest report, Phaxiam Biotech's total number of shares stands at 10,013,719. The total voting rights have also been reported, with gross voting rights being 10,165,848, and net voting rights at 10,165,597.
The Importance of Voting Rights
Voting rights are crucial for shareholders as they represent the power to influence corporate decisions. In structured corporations like Phaxiam Biotech, these numbers reflect the level of shareholder engagement and authority in the company's governance.
Monthly Summary of Shares and Voting Rights
An overview of recent statistics shows the ongoing changes in shares and voting rights. For instance, in the month preceding this update, specifically on October 8, 2024, the figures recorded were almost identical to those at the end of October. This indicates a stable environment for Phaxiam Biotech and a steady structure of share capital.
Detailed Share Data
Here’s a snapshot of share data over recent months:
- **July 1, 2024:** 9,980,668 shares with 10,132,597 gross voting rights.
- **August 29, 2024:** 10,003,719 shares with 10,165,848 gross voting rights.
- **September 30, 2024:** 10,013,719 shares continuing to show healthy engagement from investors.
Looking Ahead
As we step into the future, the consistent reporting of shares and voting rights will likely attract more investors to Phaxiam Biotech. Such clarity affirms the company's transparency and commitment to its shareholders.
Phaxiam Biotech’s Commitment
Phaxiam Biotech remains dedicated to keeping its investors informed. This not only boosts investor confidence but also enhances the overall market perception of the company. Investors should remain vigilant for upcoming updates that can provide further insights into Phaxiam's plans and performance.
Frequently Asked Questions
What is the significance of voting rights in Phaxiam Biotech?
Voting rights allow shareholders to influence important corporate decisions, making them crucial for governance and investor engagement.
How many shares does Phaxiam Biotech currently have?
As of the latest update, Phaxiam Biotech has a total of 10,013,719 shares outstanding.
What are the gross voting rights reported for Phaxiam Biotech?
The gross voting rights reported are 10,165,848.
What processes are involved in calculating voting rights?
Voting rights are calculated based on all shares carrying voting rights, including both single and double voting rights.
Where can I find more information about Phaxiam Biotech?
Investors can visit Phaxiam Biotech’s official website for detailed information about their operations and financial updates.
